Back to mobile site

Oppenheimer Reiterates Outperform Rating on Everus (ECG)

March 12, 2025 6:17 AM EDT Send to a Friend
Oppenheimer analyst Ian Zaffino reiterated an Outperform rating and $60.00 price target on Everus (NYSE: ECG).The analyst commented: "Management emphasized ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login